These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7560253

  • 1. Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.
    Hinderling PH, Tendolkar A, Dee CM, Barr WH, Seiberling M, Duerr H.
    J Clin Pharmacol; 1995 Jul; 35(7):721-9. PubMed ID: 7560253
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
    Wagner F, Jähnchen E, Trenk D.
    Eur J Clin Pharmacol; 1989 Jul; 36(6):579-82. PubMed ID: 2570700
    [Abstract] [Full Text] [Related]

  • 3. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
    Greenberg S, Cantor E, Paul J.
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
    Nanoff C, Schütz W.
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):837-42. PubMed ID: 1725895
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
    Trenk D, Wagner F, Sachs W, Jähnchen E.
    Eur J Clin Pharmacol; 1989 Dec; 37(3):313-6. PubMed ID: 2612546
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
    Labbé L, O'Hara G, Lefebvre M, Lessard E, Gilbert M, Adedoyin A, Champagne J, Hamelin B, Turgeon J.
    Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
    [Abstract] [Full Text] [Related]

  • 8. Influence of the new class I antiarrhythmic agent diprafenone on the end-systolic pressure-volume relationship (conductance technique).
    Thormann J, Kramer W, Kremer P, Schlepper M.
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):145-54. PubMed ID: 2487530
    [Abstract] [Full Text] [Related]

  • 9. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
    Groschner K, Lindner W, Schnedl H, Kukovetz WR.
    Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
    [Abstract] [Full Text] [Related]

  • 10. Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone--a novel antiarrhythmic agent.
    Koytchev R, Alken RG, Mayer O, Smith I, Greenwood M.
    Eur J Clin Pharmacol; 1996 Mar; 50(4):315-9. PubMed ID: 8803526
    [Abstract] [Full Text] [Related]

  • 11. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H.
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [Abstract] [Full Text] [Related]

  • 12. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
    Gülker H, Heuer H, Thale J, Behrenbeck T.
    Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162
    [Abstract] [Full Text] [Related]

  • 13. Effect of diprafenone on the pharmacokinetics of digoxin.
    Koytchev R, Alken RG, Mayer O.
    Eur J Clin Pharmacol; 1996 Jul; 50(1-2):97-100. PubMed ID: 8739818
    [Abstract] [Full Text] [Related]

  • 14. [HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma].
    Zhong D, Blume H.
    Pharmazie; 1994 Jan; 49(1):38-41. PubMed ID: 8140128
    [Abstract] [Full Text] [Related]

  • 15. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
    Wellstein A, Palm D, Pitschner HF, Belz GG.
    Eur J Clin Pharmacol; 1985 Jan; 29(2):131-47. PubMed ID: 3000793
    [Abstract] [Full Text] [Related]

  • 16. Enantioselective determination of diprafenone in human plasma.
    Zhong D, Chen R, Fieger-Büschges H, Blume H.
    Pharmazie; 1997 Feb; 52(2):106-9. PubMed ID: 9122271
    [Abstract] [Full Text] [Related]

  • 17. Concentration-effect relations of 5-hydroxypropafenone in normal subjects.
    Haefeli WE, Vozeh S, Ha HR, Taeschner W, Follath F.
    Am J Cardiol; 1991 May 01; 67(11):1022-6. PubMed ID: 2018005
    [Abstract] [Full Text] [Related]

  • 18. Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone.
    Kohlhardt M, Fichtner H.
    J Membr Biol; 1988 May 01; 102(2):105-19. PubMed ID: 2458471
    [Abstract] [Full Text] [Related]

  • 19. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man.
    Yasuhara M, Yatsuzuka A, Yamada K, Okumura K, Hori R, Sakurai T, Kawai C.
    J Pharmacobiodyn; 1990 Nov 01; 13(11):681-7. PubMed ID: 2093126
    [Abstract] [Full Text] [Related]

  • 20. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ.
    Clin Pharmacol Ther; 1999 Dec 01; 66(6):594-601. PubMed ID: 10613615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.